Daily electronic monitoring of subjective and objective measures of illness activity in bipolar disorder using smartphones– the MONARCA II trial protocol: a randomized controlled single-blind parallel-group trial
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Patients with bipolar disorder often show decreased adherence with mood stabilizers and frequently interventions on prodromal depressive and manic symptoms are delayed. Recently, the MONARCA I randomized controlled trial investigated the effect of electronic self-monitoring using smartphones on depressive and manic symptoms. The findings suggested that patients using the MONARCA system had more sustained depressive symptoms than patients using a smartphone for normal communicative purposes, but had fewer manic symptoms during the trial. It is likely that the ability of these self-monitored measures to detect prodromal symptoms of depression and mania may be insufficient compared to automatically generated objective data on measures of illness activity such as phone usage, social activity, physical activity, and mobility. The Monsenso system, for smartphones integrating subjective and objective measures of illness activity was developed and will be tested in the present trial. METHODS: The MONARCA II trial uses a randomized controlled single-blind parallel-group design. Patients with bipolar disorder according to ICD-10 who previously have been treated at the Copenhagen Clinic for Affective Disorder, Denmark are included and randomized to either daily use of the Monsenso system including an feedback loop between patients and clinicians (the intervention group) or to the use of a smartphone for normal communicative purposes (the control group) for a 9-month trial period. The trial was started in September 2014 and recruitment is ongoing. The outcomes are: differences in depressive and manic symptoms; rate of depressive and manic episodes (primary); automatically generated objective data on measures of illness activity; number of days hospitalized; psychosocial functioning (secondary); perceived stress; quality of life; self-rated depressive symptoms; self-rated manic symptoms; recovery; empowerment and adherence to medication (tertiary) between the intervention group and the control group during the trial. Ethical permission has been obtained. Positive, neutral and negative findings will be published. DISCUSSION: If the system is effective in reducing depressive and/or manic symptoms (and other symptoms of bipolar disorder) and the rate of episodes, there will be basis for extending the use to the treatment of bipolar disorder in general and in larger scale. TRIAL REGISTRATION: ClinicalTrials.gov NCT02221336. Registered 26th of September 2014.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Development of the World Health Organization WHOQOL-BREF Quality of Life Assessment
THE WHOQOL GROUP (1998) · Psychological Medicine · doi:10.1017/s0033291798006667 · Cited by 7,933
SCAN: Schedules fonr Clinical Assessment in Neuropsychiatry
Wing, J. K. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810180089012 · Cited by 2,517 · cited 2×
“Inclusion criteria: All patients between the age of 18 to 75 years with a bipolar disorder diagnosis according to ICD-10 using Schedules for Clinical assessments in Neuropsychiatry (SCAN) [37] who have been treated and discharged from The Copenhagen Clinic for Affective Disorder, Denmark from the period 2004 to Januar…”
MethodBoutron, I., Moher, D., Altman, D. G., Schulz, K. F., Ravaud, P., & for the CONSORT Group* (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-4-200802190-00008 · Cited by 2,292
Bech, P., Rasmussen, N.-A., Olsen, L. R., Noerholm, V., & Abildgaard, W. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00309-8 · Cited by 975 · cited 3×
“Differences in perceived stress according to Cohen’s Perceived Stress scale, quality of life according to the WHOQOL-BREF score, self-rated depressive symptoms according to BDI, self-rated manic symptoms according to ASRM, recovery according to the Recovery Assessment Scale, empowerment according to Rogers Empowerment…”
MethodAllocation concealment in randomised trials: defending against deciphering
Schulz, K. F., & Grimes, D. A. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07750-4 · Cited by 923
Validity and reliability of the Functioning Assessment Short Test (FAST) in bipolar disorder
Rosa, A. R., Sánchez-Moreno, J., Martínez-Aran, A., Salamero, M., Torrent, C., Reinares, M., Comes, M., Colom, F., Van Riel, W., Ayuso-Mateos, J., et al. (2007) · Clinical Practice and Epidemiology in Mental Health · doi:10.1186/1745-0179-3-5 · Cited by 905
A consumer-constructed scale to measure empowerment among users of mental health services
(1997) · Psychiatric Services · doi:10.1176/ps.48.8.1042 · Cited by 854 · cited 2×
“Self Rating scale for Mania (ASRM) [44], recovery according to Recovery Assessment Scale (RAS) [45], medicine adherence according to Medicine Adherence Rating Scale (MARS) [46] and empowerment according to Rogers Empowerment Scale (RES) [47].”
MethodSPIRIT 2013: new guidance for content of clinical trial protocols
Chan, A.-W., Tetzlaff, J. M., Altman, D. G., Dickersin, K., & Moher, D. (2013) · The Lancet · doi:10.1016/s0140-6736(12)62160-6 · Cited by 298
Mobile Interventions for Severe Mental Illness: Design and Preliminary Data From Three Approaches
Depp, C. A., Mausbach, B., Granholm, E., Cardenas, V., Ben-Zeev, D., Patterson, T. L., Lebowitz, B. D., & Jeste, D. V. (2010) · Journal of Nervous & Mental Disease · doi:10.1097/nmd.0b013e3181f49ea3 · Cited by 265 · cited 1×
“Other articles reporting on electronic self-monitoring have used personal digital assistants (PDAs) [8,9], computers [10-18] and smartphones [19] as the electronic self-monitoring tools, but none of the studies have however included data on objective measures of illness activity and the effect of electronic self-monit…”
BackgroundKessing, L. V., Hansen, H. V., Hvenegaard, A., Christensen, E. M., Dam, H., Gluud, C., Wetterslev, J., & The Early Intervention Affective Disorders (EIA) Trial Group (2013) · British Journal of Psychiatry · doi:10.1192/bjp.bp.112.113548 · Cited by 219 · cited 1×
“Treatment at the Copenhagen Clinic for Affective Disorder comprised combined psychopharmacological treatment as according to the guidelines from the British Association for Psychopharmacology [35] and supporting therapy for a 2-year period [36].”
MethodSelf-citation
Cited by
The impact of digital technology on psychological treatments and their dissemination
Fairburn, C. G., & Patel, V. (2017) · Behaviour Research and Therapy · doi:10.1016/j.brat.2016.08.012 · Cited by 448
Toward clinical digital phenotyping: a timely opportunity to consider purpose, quality, and safety
Huckvale, K., Venkatesh, S., & Christensen, H. (2019) · npj Digital Medicine · doi:10.1038/s41746-019-0166-1 · Cited by 433
Dogan, E., Sander, C., Wagner, X., Hegerl, U., & Kohls, E. (2017) · Journal of Medical Internet Research · doi:10.2196/jmir.7006 · Cited by 177
Hidalgo-Mazzei, D., Mateu, A., Reinares, M., Murru, A., del Mar Bonnín, C., Varo, C., Valentí, M., Undurraga, J., Strejilevich, S., Sánchez-Moreno, J., et al. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.04.042 · Cited by 121
Oluboka, O. J., Katzman, M. A., Habert, J., McIntosh, D., MacQueen, G. M., Milev, R. V., McIntyre, R. S., & Blier, P. (2018) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx081 · Cited by 104
Metadata
- Authors
- Faurholt-Jepsen, M., Vinberg, M., Frost, M., Christensen, E. M., Bardram, J., & Kessing, L. V.
- Venue
- BMC Psychiatry
- Published
- 2014-11-25
- Volume
- 14
- Issue
- 1
- Pages
- 309-309
- ISSN
- 1471-244X (ISSN-L)
- OpenAlex
- W2108807738
- Cited by
- 87
- References
- 14
- FWCI
- 4.27
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Daily electronic monitoring of subjective and objective measures of illness activity in bipolar disorder using smartphones– the MONARCA II trial protocol: a randomized controlled single-blind parallel-group trial. https://app.cochat.ai/papers/10.1186/s12888-014-0309-5
- The paper
- Faurholt-Jepsen, M., Vinberg, M., Frost, M., Christensen, E. M., Bardram, J., & Kessing, L. V. (2014). Daily electronic monitoring of subjective and objective measures of illness activity in bipolar disorder using smartphones– the MONARCA II trial protocol: a randomized controlled single-blind parallel-group trial. BMC Psychiatry. https://doi.org/10.1186/s12888-014-0309-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.